This preview shows page 1. Sign up to view the full content.
Unformatted text preview: possess in vivo and in vitro hepatoprotective properties by maintaining the liver lipid profile. This case report evaluates the hepatoprotective effects of orally supplied Spiraling maxima. Case presentation Three Hispanic Mexican patients (a 43-year-old man, a 77-year-old man and a 44-year-old woman) underwent ultrasonography and were treated with 4.5g/day of Spiraling maxima for three months. Their blood samples before and after the treatment determined triacylglycerols, total cholesterol, high-density lipoprotein cholesterol, and almandine aminotransferase and low-density lipoprotein cholesterol levels. The results were assessed using ultrasound. Conclusion Treatment had therapeutic effects as evidenced by ultrasonography and the aminotransferase data. Hypolipidemic effects were also shown. We conclude that Spiraling maxima may be considered an alternative treatment for patients with non-alcoholic fatty liver diseases and dyslipidemic disorder....
View Full Document
This note was uploaded on 05/25/2011 for the course CHEM 1 taught by Professor Shannon during the Spring '11 term at Brown Mackie College.
- Spring '11